Revenue (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2022

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Summary of disaggregation of revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Patient services
Capitated revenue	$	13,944	$	12,897	$	28,460	$	25,227
FFS revenue	25,165		16,889		45,706		34,181
Subtotal	39,109		29,786		74,166		59,408
Dispensary revenue	20,218		17,782		38,897		35,400
Clinical research trials and other revenue	1,594		2,276		3,019		3,616
Total	$	60,921	$	49,844	$	116,082	$	98,424

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Year Ended December 31,
	2021		2020
Patient services
Capitated revenue	$	54,285	$	37,381
FFS revenue	69,789		79,436
Subtotal	$	124,074	$	116,817
Dispensary revenue	72,550		63,890
Clinical research trials and other revenue	6,379		6,808
Total	$	203,003	$	187,515